{"id":399238,"date":"2025-05-28T01:05:00","date_gmt":"2025-05-27T23:05:00","guid":{"rendered":"https:\/\/medizinonline.com\/benefits-and-risks-what-does-the-current-data-say\/"},"modified":"2025-05-28T02:46:11","modified_gmt":"2025-05-28T00:46:11","slug":"benefits-and-risks-what-does-the-current-data-say","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/benefits-and-risks-what-does-the-current-data-say\/","title":{"rendered":"Benefits and risks: What does the current data say?"},"content":{"rendered":"\n

Although there have been no recent approvals of oral JAK inhibitors (JAK-i) for atopic dermatitis (AD), some interesting study findings have been published. These shed light on the safety of baricitinib, abrocitinib and upadacitinib with reference to the EMA opinion on JAK-i issued some time ago. In the EU, baricitinib has now been given an extended indication for AD patients aged 2 years and older. <\/strong><\/p>\n\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

Although there have been no recent approvals of oral JAK inhibitors (JAK-i) for atopic dermatitis (AD), some interesting study findings have been published. These shed light on the safety of……... <\/p>\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":399241,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Oral JAK-i in atopic dermatitis ","footnotes":""},"category":[11331,11513,11340,11548,11503],"tags":[67753,12624,82476,82478,65581,17427,65710,22621,68784,18776,17435,69983,65578,16781,15545,20431,16782,82477],"powerkit_post_featured":[],"class_list":["post-399238","post","type-post","status-publish","format-standard","has-post-thumbnail","category-allergology-and-clinical-immunology","category-congress-reports","category-dermatology-and-venereology","category-rx-en","category-studies","tag-abrocitinib-en","tag-atopic-dermatitis-en","tag-barictinib-en","tag-breeze-ad-peds-en","tag-cibinqo-en","tag-jak-inhibitors","tag-jak-i-en","tag-jak-inhibitor-en-2","tag-janus-kinases","tag-meta-analysis","tag-olumiant-en","tag-oral-surveillance-en","tag-rinvoq-en","tag-risks","tag-small-molecules-en","tag-upadacitinib-en","tag-use","tag-yoon-en","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-19 01:57:23","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":399205,"slug":"les-benefices-et-les-risques-que-disent-les-donnees-actuelles","post_title":"les b\u00e9n\u00e9fices et les risques : Que disent les donn\u00e9es actuelles ?","href":"https:\/\/medizinonline.com\/fr\/les-benefices-et-les-risques-que-disent-les-donnees-actuelles\/"},"it_IT":{"locale":"it_IT","id":399207,"slug":"benefici-e-rischi-cosa-dicono-i-dati-attuali","post_title":"Benefici e rischi: Cosa dicono i dati attuali?","href":"https:\/\/medizinonline.com\/it\/benefici-e-rischi-cosa-dicono-i-dati-attuali\/"},"pt_PT":{"locale":"pt_PT","id":399210,"slug":"beneficios-e-riscos-o-que-dizem-os-dados-actuais","post_title":"Benef\u00edcios e riscos: O que dizem os dados actuais?","href":"https:\/\/medizinonline.com\/pt-pt\/beneficios-e-riscos-o-que-dizem-os-dados-actuais\/"},"es_ES":{"locale":"es_ES","id":399231,"slug":"beneficios-y-riesgos-que-dicen-los-datos-actuales","post_title":"Beneficios y riesgos: \u00bfQu\u00e9 dicen los datos actuales?","href":"https:\/\/medizinonline.com\/es\/beneficios-y-riesgos-que-dicen-los-datos-actuales\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/399238","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=399238"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/399238\/revisions"}],"predecessor-version":[{"id":399242,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/399238\/revisions\/399242"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/399241"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=399238"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=399238"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=399238"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=399238"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}